CSIMarket
 


Biotricity Inc   (BTCY)
Other Ticker:  
 

Cumulative Biotricity Inc 's Working Capital Ratio for Trailing Twelve Months Period

BTCY's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

BTCY Working Capital Ratio for Trailing Twelve Months Period

(Mar 31 2024)
IV. Quarter
(Dec 31 2023)
III. Quarter
(Jun 30 2023)
I. Quarter
(Mar 31 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
Y / Y Current Liabilities Growth 211.34 % 324.24 % 229.83 % 129.33 % 50.98 %
Y / Y Current Assets Growth -6.75 % -41.76 % -59.43 % -69.19 % -75.55 %
Working Capital Ratio for Trailing Twelve Months Period 0.26 0.34 0.54 0.99 1.79
Total Ranking # 2775 # 3194 # # 3739 # 3567
Seq. Current Liabilities Growth 21.91 % 23.32 % 35.27 % 53.08 % 66.12 %
Seq. Current Assets Growth 13.68 % -10.64 % -6.77 % -1.55 % -28.99 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Mar 31 2024
On the trailing twelve months basis Due to growth in Current Liabilities in the IV. Quarter to $23 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 0.26 below Biotricity Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 159 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Biotricity Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about BTCY
Working Capital Ratio BTCY in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 160
Sector # 638
S&P 500 # 2797


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
3.06 0.86 0.17
(Jun 30 2022)   (Sep 30 2019)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2024, within Medical Equipment & Supplies Industry Working Capital Ratio for Trailing Twelve Months Period
Vivos Therapeutics Inc   0.67 
Regenicin Inc   0.63 
Sep Acquisition Corp   0.57 
Nemaura Medical Inc   0.56 
Nu med Plus Inc   0.54 
P3 Health Partners Inc   0.49 
Seastar Medical Holding Corporation  0.48 
Vystar Corporation  0.46 
Qt Imaging Holdings Inc   0.44 
Guided Therapeutics Inc   0.44 
Biotricity Inc   0.30 
Biosig Technologies Inc   0.29 
Yubo International Biotech Limited  0.27 
Northview Acquisition Corp   0.26 
Invo Bioscience Inc   0.26 
Spectral Ai Inc   0.22 
G Medical Innovations Holdings Ltd   0.22 
Arch Therapeutics Inc   0.18 
Therapeutic Solutions International Inc   0.18 
Electromedical Technologies inc   0.17 
Non Invasive Monitoring Systems Inc  0.16 
Vycor Medical Inc   0.14 
Sanuwave Health Inc   0.12 
Qhslab Inc   0.12 
Neuraxis Inc   0.12 
Dih Holding Us Inc   0.11 
Altair International Corp   0.10 
Marizyme Inc   0.10 
Carmell Corporation  0.10 
Legacy Ventures International Inc  0.09 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com